Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Pelthos Therapeutics Inc. (PTHS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Pelthos Therapeutics Inc. (PTHS), most recent 12 months reported: revenue $43.3M, net loss $86.39M, free cash flow -$22.69M. Latest balance sheet on file: liquid cash $24.19M, total debt $69.91M, net cash -$45.72M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): BioStem Technologies, Inc. · EDITAS MEDICINE, INC. · SUTRO BIOPHARMA, INC. · PRECISION BIOSCIENCES INC · C4 Therapeutics, Inc. · SANGAMO THERAPEUTICS, INC. · Voyager Therapeutics, Inc. · Scilex Holding Company

Stock screener

Watchlist